Literature DB >> 7588842

Value of specific immunoglobulin A detection by two immunocapture assays in the diagnosis of toxoplasmosis.

F Foudrinier1, C Marx-Chemla, D Aubert, A Bonhomme, J M Pinon.   

Abstract

The diagnosis of Toxoplasma gondii infection is currently based on immunological tests, but tests for IgG and IgM antibodies alone are often insufficient to assess the risk of active disease, especially during pregnancy and in immunodeficient subjects. The supplementary diagnostic value of testing for antitoxoplasmic IgA in cases of acute, chronic, congenital and reactivated toxoplasmosis, relative to classical immunological tests, was evaluated using two immunocapture tests, one based on tachyzoite agglutination and the other on an immunoenzymatic complex recognizing the membrane protein P30 of Toxoplasma gondii. A total of 4,541 sera from 395 uninfected subjects, 468 immunized subjects with chronic infection, 117 subjects with acute infection and 403 children, 103 of whom had congenital toxoplasmosis, was tested. Specific IgA tests were negative in the nonimmune population, but tests for this immunoglobulin subtype became positive very rapidly during primary infection, and IgA disappeared more rapidly than IgM. In the children infected in utero, specific IgA was detected more frequently than IgM. In contrast, in a population of HIV-seropositive subjects with clinical toxoplasmosis, tests for IgA were poorly sensitive. The two tests for specific IgA produced similar results, except in the early stages of primary infection, in which immunoenzymatic testing for anti-P30 IgA was less sensitive than the agglutination method.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588842     DOI: 10.1007/BF01690729

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  IgA antibodies against P30 as markers of congenital and acute toxoplasmosis.

Authors:  A Decoster; F Darcy; A Caron; A Capron
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

2.  IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  P Stepick-Biek; P Thulliez; F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

3.  [Specific serum IgAs in the diagnosis of toxoplasmosis].

Authors:  Y Le Fichoux; P Marty; H Chan
Journal:  Ann Pediatr (Paris)       Date:  1987-05

4.  Toxoplasma parasitaemia associated with serological reactivation of chronic toxoplasmosis in a patient with the acquired immunodeficiency syndrome.

Authors:  F Derouin; D Vittecoq; B Beauvais; A Bussel
Journal:  J Infect       Date:  1987-03       Impact factor: 6.072

5.  An enzyme-linked immuno-filtration assay used to compare infant and maternal antibody profiles in toxoplasmosis.

Authors:  J M Pinon; H Thoannes; N Gruson
Journal:  J Immunol Methods       Date:  1985-02-28       Impact factor: 2.303

6.  [Value and limitations of toxoplasmosis serology in HIV patients].

Authors:  F Derouin; P Thulliez; Y J Garin
Journal:  Pathol Biol (Paris)       Date:  1991-04

7.  Toxoplasma antigens recognized by naturally occurring human antibodies.

Authors:  I Potasman; F G Araujo; J S Remington
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

8.  Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies.

Authors:  A Decoster; B Slizewicz; J Simon; C Bazin; F Darcy; G Vittu; C Boulanger; Y Champeau; J L Demory; M Duhamel
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.

Authors:  J M Pinon; F Foudrinier; G Mougeot; C Marx; D Aubert; O Toupance; G Niel; M Danis; P Camerlynck; G Remy
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Prevalence of latent toxoplasmosis and serological diagnosis of active infection in HIV-positive patients.

Authors:  J Zufferey; A Sugar; P Rudaz; J Bille; M P Glauser; J P Chave
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

View more
  14 in total

1.  Lack of value of specific IgA detection in the postnatal diagnosis of congenital toxoplasmosis.

Authors:  A K Faure; H Fricker-Hidalgo; H Pelloux; C Bost-Bru; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies.

Authors:  J M Pinon; C Chemla; I Villena; F Foudrinier; D Aubert; D Puygauthier-Toubas; B Leroux; D Dupouy; C Quereux; M Talmud; T Trenque; G Potron; M Pluot; G Remy; A Bonhomme
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Assessment of the IgA immunosorbent agglutination assay for the diagnosis of congenital toxoplasmosis on a series of 145 toxoplasmic seroconversions.

Authors:  J B Murat; A Souvignet; H Fricker-Hidalgo; M P Brenier-Pinchart; C Bost-Bru; H Pelloux
Journal:  Clin Vaccine Immunol       Date:  2015-02-11

5.  Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis.

Authors:  F Foudrinier; I Villena; R Jaussaud; D Aubert; C Chemla; F Martinot; J M Pinon
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Urine sample used for congenital toxoplasmosis diagnosis by PCR.

Authors:  I Fuentes; M Rodriguez; C J Domingo; F del Castillo; T Juncosa; J Alvar
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies.

Authors:  J M Pinon; H Dumon; C Chemla; J Franck; E Petersen; M Lebech; J Zufferey; M H Bessieres; P Marty; R Holliman; J Johnson; V Luyasu; B Lecolier; E Guy; D H Joynson; A Decoster; G Enders; H Pelloux; E Candolfi
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases.

Authors:  F Robert-Gangneux; M F Gavinet; T Ancelle; J Raymond; C Tourte-Schaefer; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

9.  Diagnosis of toxoplasmosis by joint detection of immunoglobulin A and immunoglobulin M.

Authors:  M Arcavi; G Orfus; G Griemberg
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

10.  Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  V Rilling; K Dietz; D Krczal; F Knotek; G Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.